- Entry
- $7.59
- Now
- $12.70 +67.3%
- Target
- —
- Score
- —
SLS has been ripping recently because of their REGAL trial ending soon. They got a drug called GPS meant to treat a type of Leukemia. Their trial is at 78 /80 events meaning we're waiting for the last two people to finish the trial. This is gonna be a huge binary event, they a previous Phase 2 CR2 AML trial which showed median overall survival of 16.3 months vs 5.4 months of the control arm. So I reckon the regal …
— ORIGINAL POST ·
All in on cancer $SLS
· r/wallstreetbets
· May 20, 2026